Baxter recently adjusted its global supply network and the IV therapy products made by its Shanghai plant will stop being supplied to ... However, its peritoneal dialysis solution business, which ...

Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at ...

--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product launches in the ...

The five recent product launches within Baxter’s Pharmaceuticals portfolio in the U.S. include the following. For all products, please see full Indications, including Limitations of Use ...

New launches reinforce Baxter’s leadership in bringing high-value, specialty injectable products to market to help address critical patient needs Products help support patient safety ...